Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
988.05Prev. Close
983.25Volume
23,456Total traded value
2.27 CrUpper Circuit
1,179.90Lower Circuit
786.60Fundamentals
| Market Cap | ₹12,055Cr |
| ROE | 17.24% |
| P/E Ratio(TTM) | 24.32 |
| EPS(TTM) | 40.40 |
| P/B Ratio | 4.28 |
| Dividend Yield | 0.51% |
| Industry P/E | 40.64 |
| Book Value | 229.65 |
| Debt to Equity | 0.02 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Alivus Life Sciences
Glenmark Life Sciences is a leading developer and manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), the key components used in making medicines. The company's vision is to be the most valued API player in the industry by applying science and engineering to deliver affordable, high-quality products. Its global API distribution network serves over 700 customers across more than 75 countries.;
| Parent Organisation | Alivus Life Sciences |
| Managing Director | Dr. Yasir Rawjee |
| NSE Symbol | ALIVUS |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 102.84 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.38 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.75 | ||
| Wockhardt | NA (0.00%) | -195.00 |